Innovation is at the center of everything we do.

Our long history of scientific leadership includes the discoveries of vitamin B1 and troglitazone, and the first isolation of epinephrine – better known as adrenaline. Our research has led to new classes of pharmaceuticals for hypertension, oncology and more, such as the discovery of the statin class of lipid-lowering agents and the development of the first glitazone, which revolutionized long-term control of type 2 diabetes.

About Icon1

Today, innovation remains at the center of everything we do. We build on our legacy through ongoing research to create world-class medicines, pairing existing ideas with new ones, as we pursue our highest goal: to improve quality of life for patients around the globe.

About Icon2

What Sets Us Apart

We know that our success is linked to the success of our employees. Each member of our organization contributes to our pursuit of our goals and our company vision. We hold ourselves to high standards in a competitive industry – but our culture sets us apart. Daiichi Sankyo is proud to foster an environment of collaboration and ideas.

Our Culture
About Icon3

Products & Pipeline

Our comprehensive product portfolio offers a wide range of treatments for patients in a number of disease categories including hypertension, heart disease, diabetes and hyperlipidemia/ atherosclerosis. Our pipeline of compounds focuses on these product categories and explores oncology therapies.

Training & Education
About Icon4

Giving Back

Our commitment to improving lives is the core of our business, but it doesn’t end with our products and pipeline. We are proud members of the communities in which we live and work, as individuals and as an organization. Through corporate philanthropy, community service, patient assistance and more, we’re moving forward by giving back.

Our Benefits

Innovation. Integrity. Accountability.

About Thumb1

Our Legacy in Action

Established in 2006 by the merger of two 100-year-old Japanese pharmaceutical companies, Daiichi Sankyo, Inc. is headquartered in New Jersey. The organization includes U.S. commercial operations and global drug development.

We offer a unique blend of an entrepreneurial environment and a collaborative culture, and the innovation that propels us forward comes from all corners of our company. At Daiichi Sankyo, good ideas don't just happen in the lab, but also in conference rooms, at desks and in the field, contributed both by individuals and groups.

Our passion for bringing drugs to patients is unmistakable. We invest in the development of our people as much as our business goals, and each member of our community plays a role in our achievements. We're proud of what we've done, and even more proud of where we'll go from here.